Company profile
Envoy Medical, Inc.
NASDAQ: COCH · Healthcare · Medical - Devices
#988 of 1,418 Healthcare companies by revenue52nd-percentile growth
EA Score
33DFH 22DQ 39GM 53SS 40
v0.1 · 65/100 weight · provisional
↑ growth stability, filing timeliness · ↓ operating margin, net margin
Methodology →Revenue TTM
$234.0k
Rev growth YoY (TTM)
+10.4%
Net income (FY)
-$23.8M
Employees
43
as of 2026-08-21
Market cap
$15.6M
as of 2026-08-21
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$241.0k$241.0k2025
Net income-$23.8M-$23.8M2025
Operating income-$22.3M-$22.3M2025
Total assets$8.6M$8.6M2025
Liabilities$20.3M$20.3M2025
Equity-$12.2M-$12.2M2025
Revenue trend
FY2023 – FY2025 · USD
FY23
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Other Operating100%
By geography
Not disclosed.
The read
What is Envoy Medical, Inc.’s revenue?
Envoy Medical, Inc. booked $241.0k in FY2025 revenue, growing 7.1% year over year — about the middle of the pack among Healthcare companies we track, at a -9857.3% net margin.
Peers · Healthcare
Nexteligent Holdings, Inc.46DAdhera Therapeutics Inc——Bluejay Diagnostics, Inc.33DWellness Center USA, Inc.——LiveWire Ergogenics, Inc.——Sproutly Canada Inc.——Neighbors
Ramsey →Key facts
CEOBrent T. Lucas
SectorHealthcare
IndustryMedical - Devices
HeadquartersWhite Bear Lake, MN
ExchangeNASDAQ: COCH
Employees43
IPO date2021-04-29
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.